AmySusanDuffieldMD

Pathology • New York, NY

Hematopathology, Anatomic Pathology, Clinical Pathology

Professor of Pathology, Icahn School of Medicine at Mount Sinai Hospital

Join to view full profile

Dr. Duffield is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Duffield's full profile

Already have an account?

Office
1275 York Ave
New York, NY 10065
Phone+1 212-639-5900

Education & Training

Johns Hopkins UniversityFellowship, Hematopathology, 2009 - 2010
Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2005 - 2009
Yale School of MedicineClass of 2005

Certifications & Licensure

NY State Medical License 2020 - 2025
NJ State Medical License 2021 - 2023
MD State Medical License 2010 - 2020
PA State Medical License 2008 - 2010
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition.
Ruiqi Zhu, Courtney M Shirley, S Haihua Chu, Li Li, Bao H Nguyen
Leukemia. 2024-07-01
2 citations
Regression of smoldering myeloma with treatment of Gaucher disease.
Kevin Barley, Anshuman Parekh, Syed Salam, Damodara Rao Mendu, Ravi Prakash Shukla
Blood Advances. 2024-04-09
1 citations
Phenotypic and genotypic infidelity in B-lineage neoplasms, including transdifferentiation following targeted therapy: Report from the 2021 SH/EAHP Workshop.
John R Goodlad, Wenbin Xiao, Catalina Amador, James R Cook, Lanie Happ
American Journal of Clinical Pathology. 2023-06-01

Abstracts/Posters

DOCK2 Expression Affects Leukemogenesis and Disease Progression in a Murine Model of FLT3/ITD Acute Myeloid Leukemia
Amy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
The High Mobility Group A1 Chromatin Regulator Is Required for Pathologic Megakaryocyte Development and Progression to Myelofibrosis in JAK2V617F Murine Models
Amy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Gilteritinib and Venetoclax Synergize to Eliminate FLT3/ITD+ Leukemia Cells through BIM
Amy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Journal of HematopathologyFebruary 20th, 2019
Researchers Link Organ Transplant Drug to Rise in Rare LymphomaFebruary 10th, 2016

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/amy-duffield